#

+1 (917) 893 7512

  • #
  • #
  • #
#
Global Healthcare CMO Market Growth,Trends & Forecast (2020-2024)

Global Healthcare CMO Market: Size and Forecasts with Impact Analysis of Covid-19 (2020-2024)

Publish Date:Apr 2020
No. of Pages:61

Format : Adobe Reader (PDF) Instant delivery

US$ 850.00

Scope of the Report

Best Global Healthcare CMO Market Report from 2020 to 2024

The report entitled “Global Healthcare CMO Market: Size and Forecasts with Impact Analysis of Covid-19 (2020-2024)” provides a detailed analysis global healthcare CMO market with impact of Covid-19 and market sizing. The analysis includes market size in terms of value, and market share by segments. A comprehensive segment analysis has also been provided in the report with their historical and forecasted value.

Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and would be driving the growth of the industry. Growth of the overall healthcare CMO market has also been forecasted for the period 2020-2024, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

The market is highly fragmented. According to estimates, there are up to 1,000 companies currently active in the market. The players are either pure play service providers or pharmaceutical companies who are willing to make optimum use of their spare manufacturing and development capacities. Company profiling of major players of healthcare CMO industry such as Catalent Pharma Solution, Recipharm, Aurobindo Pharma Ltd. and Boehringher Ingelheim has been done in the report. This segment of the report provides business overview, financial overview, and business strategies adopted by the respective companies.

Company Coverage

Catalent Pharma Solution
Recipharm
Auribindo Pharma Ltd.
Boehringer Ingelheim

Regional Coverage

Asia Pacific

Executive Summary

An outsourcing in which a pharmaceutical firm contacts with a third party (contract manufacturing organization) for the manufacturing of components of its product or whole of its product is known as contract manufacturing. A contract manufacturing organization (CMO) undertakes the production of product(s) under the brand name of another firm.

A firm either big or mid-size selects a CMO for primarily two reasons: it wants to shift (or cut) its cost and focus to its core activities, or the development of its products require special or expert handling.

CMOs provide independent manufacturing services in healthcare sector also. Healthcare CMOs can be segmented into pharmaceutical CMOs and medical device CMOs. After the discovery of chemical formula of a new drug, the pharmaceutical CMOs are given the task of manufacturing it into a whole product, so that the pharmaceutical companies are able to sell it into the market under their brand name. Services offered by pharmaceutical CMOs can be divided into two main activities: primary manufacturing (Active Pharmaceutical Ingredients) and secondary manufacturing (Finished Dosage Formulation). Contract manufacturing for medical devices is one of the fastest growing segments of the medical device industry, as companies are in the race to bring new devices to the market.

The global healthcare CMO market has recorded continuous growth over the past few years and is expected to follow the same trend in coming years. The main driving factors for this growth are rise in global pharmaceutical industry, increased need for outsourcing, increased approvals and outsourcing of NMEs, innovations and increased regulatory pressure on quality. Yet there are some challenges, which healthcare CMO industry faces, such as fragmented nature of market, less preference for outsourcing of profitable and biological drugs by big pharmaceutical companies.


Tags :







1. Executive Summary

2. Introduction

2.1 Contract Manufacturing: An Overview

2.1.1 Healthcare CMOs 
2.1.2 Healthcare CMOs Market Segments
2.1.3 Pharmaceutical CMOs
Active Pharmaceutical Ingredients (API)
Finished Dosage Formulations (FDF)
2.1.4 Medical CMOs

2.2 Pharmaceutical Outsourcing: An Overview
2.2.1 Pharmaceutical Outsourcing Market Segments

2.3 Pharmaceutical CMOs v/s CDMOs 

3. Global Market Analysis

3.1 Global Healthcare CMO Market Analysis 

3.1.1 Global Healthcare CMO Market by Value 
3.1.2 Global Healthcare CMO Market by Segments (Medical Devices CMO and Pharmaceutical CMO) 

3.2 Global Healthcare CMO Market: Segment Analysis 

3.2.1 Global Medical Device CMO Market by Value 
3.2.2 Global Pharmaceutical CMO Market by Value 

3.3 Global Pharmaceutical CMO Market Analysis 
3.3.1 Global Pharmaceutical CMO Market by Segments (Active Pharmaceutical Ingredient, Finished Dosage Formulation and Packaging)

3.4 Global Pharmaceutical CMO Market: Segment Analysis 
3.4.1 Global Active Pharmaceutical Ingredient CMO Market by Value

3.5 Global Healthcare  CMO Market Regional Analysis 
3.5.1 Global Healthcare CMO Market by Region (Asia Pacific and Rest of the World)

4. Regional Analysis

4.1 Asia Pacific Healthcare CMO Market Analysis 
4.1.1 Asia Pacific Healthcare CMO Market by  Value

5. Impact of Covid-19

5.1 Global Pharmaceutical CDMO Market Analysis 
5.1.1 Global Pharmaceutical CDMO Market by  Value

5.2 Surge in Contracts to CDMOs
5.3 Supply Chain Issues amidst Surge in Demand for CDMOs
5.4 Prepardeness in the Event of Supply Chain Disruption

6. Competitive Landscape

6.1 Global Healthcare CMO Market Players Financial Comparison

7. Company Profiles

7.1 Catalent Inc.
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy

7.2 Recipharm 
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy

7.3 Aurobindo Pharma Limited
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy

7.4 Boehringer Ingelheim
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategy
Figure 1: Healthcare CMOs Market Segments
Figure 2: Pharmaceutical Outsourcing Market Segments
Figure 3: Value Chain of a Drug
Figure 4: Global Healthcare CMO Market by Value; 2018-2019 (US$ Billion)
Figure 5: Global Healthcare CMO Market by Value; 2020-2024 (US$ Billion)
Figure 6: Global Healthcare CMO Market by Segments; 2019
Figure 7: Global Medical Device CMO Market by Value; 2018-2019 (US$ Billion)
Figure 8: Global Medical Device CMO Market by Value; 2020-2024 (US$ Billion)
Figure 9: Global Pharmaceutical CMO Market by Value; 2018-2019 (US$ Billion)
Figure 10: Global Pharmaceutical CMO Market by Value; 2020-2024 (US$ Billion)
Figure 11: Global Pharmaceutical CMO Market by Segments; 2019 (Percentage,%)
Figure 12: Global Active Pharmaceutical Ingredient CMO Market by Value; 2018-2019 (US$ Billion)
Figure 13: Global Active Pharmaceutical Ingredient CMO Market by Value; 2020-2024 (US$ Billion)
Figure 14: Global Healthcare CMO Market by Region; 2019 (Percentage,%)
Figure 15: Asia Pacific CMO Market by Value; 2018-2019 (US$ Billion)
Figure 16: Asia Pacific CMO Market by Value; 2020-2024 (US$ Billion)
Figure 17: Global Pharmaceutical CDMO Market by Value; 2018-2019 (US$ Billion)
Figure 18: Global Pharmaceutical CDMO Market by Value; 2020-2024 (US$ Billion)
Figure 19: Catalent, Inc. Revenue; 2015-2019 (US$ Billion)
Figure 20: Catalent, Inc. Revenue by Segments; 2019
Figure 21: Recipharm Net Sales; 2015-2019 (US$ Million)
Figure 22: Recipharm Net Sales by Segments; 2019
Figure 23: Recipharm Net Sales by Region; 2019
Figure 24: Aurobindo Revenues; 2015-2019 (US$ Billion)
Figure 25: Aurobindo Revenues by Segments; 2019
Figure 26: Boehringher Ingelheim Net Sales; 2015-2019 (US$ Billion)
Figure 27: Boehringher Ingelheim Net Sales by Geography; 2019
Figure 28: Boehringher Ingelheim Net Sales by Business; 2019
Table 1: Contracts placed with Pharmaceutical CDMOs; 2020
Table 2: Global Healthcare CMO Market Players Financial Comparison; 2019